Facebook
Twitter
LinkedIn
ForwardFebruary 26, 2024 - Cellular Therapies
Please note, access to symposium recordings is included with registration.
Access will be available for 30 days post event.
With several new drug and cellular therapies as well as an expansion of our understanding of the biologic heterogeneity of hematologic malignancies, there is a need for ongoing education in the area of hematologic malignancies. This interactive webinar series will focus on current best practices, and how those are evolving based on major updates in the biology, diagnosis, and management of hematologic malignancies. Attendee interaction is encouraged and promoted through the designated time for audience questions at the end of each webinar. Each 90-minute webinar will have two talks followed by discussion and audience Q&A. Presenters will include internationally-known disease experts from Mass General Cancer Center covering high-yield practice-changing updates in cellular therapies, transplant, myeloma, leukemia, and lymphoma.
Target Audience
This activity is intended for physicians, nurses, pharmacists, other members of healthcare team (regional) with specialties such as general practice, hematology, hematology/oncology, medical oncology, primary care, and radiation oncology.
Learning Objectives
Upon completion of this activity, participants will be able to:
- Discuss practice-changing updates in cellular therapy.
- Identify new cellular therapies and indications for cellular therapy.
Additional Information
Massachusetts General Hospital Cancer Center & Mass General Brigham
| 5:00pm | Cellular Therapy in Lymphoma |
| 5:30pm | Cellular Therapy Updates in Myeloma, Leukemia & Toxicity Management |
| 6:00pm | Q&A/Discussion |
| 6:30pm | Adjourn |
Course Director
 | P. Connor Johnson, MD Hematology/Oncology, Massachusetts General Hospital Cancer Center Instructor in Medicine, Harvard Medical School |
Speakers
 | Matthew Frigault, MD Administrative Director, Cellular Therapy Service, Massachusetts General Hospital Cancer Center Assistant Professor of Medicine, Harvard Medical School |
| P. Connor Johnson, MD Hematology/Oncology, Massachusetts General Hospital Cancer Center Instructor in Medicine, Harvard Medical School |
In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statements
AMA PRA Category 1 CreditsTM
Mass General Brigham designates this live activity for a maximum of 1.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing
Mass General Brigham designates this activity for 1.5 ANCC contact hours. Nurses should only claim credit commensurate with the extent of their participation in the activity.
Pharmacy
This activity provides 1.5 contact hours (1.5 CEUs) of continuing education credit. ACPE Universal Activity Number (UAN): JA0007437-0000-24-001-L01-P
Pharmacy Technicians
This activity provides 1.5 contact hours (1.5 CEUs) of continuing education credit. ACPE Universal Activity Number (UAN): JA0007437-0000-24-001-L01-T
Available Credit
- 1.50 ACPE Pharmacy
- 1.50 ACPE Technician
- 1.50 AMA PRA Category 1 Credit™
- 1.50 Nursing Contact Hours
- 1.50 Participation
Price
CANCELLATION POLICY:
Registrations cancelled on or before February 12, 2024 will be refunded, less a $20 administrative fee. Registrations cancelled after February 12, 2024 will not be refunded.
Contact partnerscpd@partners.org if you require assistance in cancelling your online registration.